Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Weckermann

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancerDorothea Weckermann, Bernhard Polzer, Thomas Ragg, et al.
Pathology|February 28, 2022
IgG4-related pseudotumours: a series of 12 cases and a review of the literatureAndrea Maccagno, Bianca Grosser, László Füzesi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2006
A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patientsRalf Oberneder, Dorothea Weckermann, Beatrice Ebner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
An Intrapatient Dosimetry Comparison of <sup>177</sup>Lu-rhPSMA-10.1 and <sup>177</sup>Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate CancerAndreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
BMC Microbiology|July 31, 2007
HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasiaRainer Voisard, Tanja Krügers, Barbara Reinhardt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2016
Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate CancerArndt-Christian Müller, Franziska Eckert, Frank Paulsen, et al.
Cancer Research|January 10, 2002
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer, Alfred Zippelius, Ralf Lutterbüse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Advances in Therapy|October 10, 2020
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)Maximilian Pallauf, Marie C Hempel, Marie C Hupe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancerDorothea Weckermann, Bernhard Polzer, Thomas Ragg, et al.
Pathology|February 28, 2022
IgG4-related pseudotumours: a series of 12 cases and a review of the literatureAndrea Maccagno, Bianca Grosser, László Füzesi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2006
A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patientsRalf Oberneder, Dorothea Weckermann, Beatrice Ebner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
An Intrapatient Dosimetry Comparison of <sup>177</sup>Lu-rhPSMA-10.1 and <sup>177</sup>Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate CancerAndreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
BMC Microbiology|July 31, 2007
HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasiaRainer Voisard, Tanja Krügers, Barbara Reinhardt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2016
Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate CancerArndt-Christian Müller, Franziska Eckert, Frank Paulsen, et al.
Cancer Research|January 10, 2002
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer, Alfred Zippelius, Ralf Lutterbüse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Advances in Therapy|October 10, 2020
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)Maximilian Pallauf, Marie C Hempel, Marie C Hupe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Pageof 4